Pablo Romero-Morelos
Mexican Social Security Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pablo Romero-Morelos.
Infectious Agents and Cancer | 2012
Raúl Peralta-Rodríguez; Pablo Romero-Morelos; Vanessa Villegas-Ruíz; Mónica Mendoza-Rodríguez; Keiko Taniguchi-Ponciano; Beatriz González-Yebra; Daniel Marrero-Rodríguez; Mauricio Salcedo
BackgroundHuman Papillomavirus (HPV) in cervical epithelium has been identified as the main etiological factor in the developing of Cervical Cancer (CC), which has recently become a public health problem in Mexico. This finding has allowed for the development of vaccines that help prevent this infection. In the present study, we aimed to determine the prevalence and HPV type-distribution in Mexican women with CC, high-grade squamous intraepithelial lesion (HSIL), low-grade squamous intraepithelial lesion (LSIL), and Normal cytology (N) to estimate the impact of the HPV vaccines.MethodsThe PubMed database was used to identify and review all articles that reported data on HPV prevalence in CC, precursor lesions, and normal cytology of Mexican women.ResultsA total of 8,706 samples of the tissues of Mexican women were stratified according to diagnosis as follows: 499 for CC; 364 for HSIL; 1,425 for LSIL, and 6,418 for N. According to the results, the most prevalent genotypes are the following: HPV16 (63.1%), -18 (8.6%), -58, and −31 (5%) for CC; HPV-16 (28.3%), 58 (12.6%), 18 (7.4%), and 33 (6.5%) for HSIL; HPV-16 (13.1%), 33 (7.4%), 18 (4.2%), and 58 (2.6%) for LSIL, and HPV-16 (3.4%), 33 (2.1%), 18, and 58 (1.2%) for N.ConclusionsTaken together, genotypes 58 and 31 (10%) are more common than type 18 (8.6%) in CC. Therefore, the inclusion of these two genotypes in a second-generation vaccine would provide optimal prevention of CC in Mexico.
BMC Cancer | 2017
Héctor Guerrero-Flores; Teresa Apresa-García; Ónix Garay-Villar; Alejandro Sánchez-Pérez; David Flores-Villegas; Artfy Bandera-Calderón; Raúl García-Palacios; Teresita Rojas-Sánchez; Pablo Romero-Morelos; Verónica Sánchez-Albor; Osvaldo Mata; Víctor Arana-Conejo; Jesús Badillo-Romero; Keiko Taniguchi; Daniel Marrero-Rodríguez; Mónica Mendoza-Rodríguez; Miriam Rodríguez-Esquivel; Victor Huerta-Padilla; Andrea Martínez-Castillo; Irma Hernández-Gallardo; Ricardo López-Romero; Cindy Bandala; Juan Rosales-Guevara; Mauricio Salcedo
BackgroundCervical Cancer (CC) has become a public health concern of alarming proportions in many developing countries such as Mexico, particularly in low income sectors and marginalized regions. As such, an early detection is a key medical factor in improving not only their population’s quality of life but also its life expectancy. Interestingly, there has been an increase in the number of reports describing successful attempts at detecting cancer cells in human tissues or fluids using trained (sniffer) dogs. The great odor detection threshold exhibited by dogs is not unheard of. However, this represented a potential opportunity to develop an affordable, accessible, and non-invasive method for detection of CC.MethodsUsing clicker training, a male beagle was trained to recognize CC odor. During training, fresh CC biopsies were used as a reference point. Other samples used included cervical smears on glass slides and medical surgical bandages used as intimate sanitary pads by CC patients. A double-blind procedure was exercised when testing the beagle’s ability to discriminate CC from control samples.ResultsThe beagle was proven able to detect CC-specific volatile organic compounds (VOC) contained in both fresh cervical smear samples and adsorbent material samples. Beagle’s success rate at detecting and discriminating CC and non-CC odors, as indicated by specificity and sensitivity values recorded during the experiment, stood at an overall high (>90%). CC-related VOC in adsorbent materials were detectable after only eight hours of use by CC patients.ConclusionPresent data suggests different applications for VOC from the uterine cervix to be used in the detection and diagnosis of CC. Furthermore, data supports the use of trained dogs as a viable, affordable, non-invasive and, therefore, highly relevant alternative method for detection of CC lesions. Additional benefits of this method include its quick turnaround time and ease of use while remaining highly accurate and robust.
Scientific Reports | 2018
Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Malayannan Subramaniam; John R. Hawse; Kevin S. Pitel; Hugo Arreola-De la Cruz; Victor Huerta-Padilla; Gustavo Ponce-Navarrete; Ma. del Pilar Figueroa-Corona; Laura Gomez-Virgilio; Teresa I. Martinez-Cuevas; Mónica Mendoza-Rodríguez; Miriam Rodríguez-Esquivel; Pablo Romero-Morelos; Jorge Ramírez-Salcedo; Michael Baudis; Marco Antonio Meraz-Ríos; Florinda Jiménez-Vega; Mauricio Salcedo
Cervical cancer (CC) is associated with alterations in immune system balance, which is primarily due to a shift from Th1 to Th2 and the unbalance of Th17/Treg cells. Using in silico DNA copy number analysis, we have demonstrated that ~20% of CC samples exhibit gain of 8q22.3 and 19q13.31; the regions of the genome that encodes the KLF10 and PSG genes, respectively. Gene expression studies demonstrated that there were no alterations in KLF10 mRNA expression, whilst the PSG2 and −5 genes were up-regulated by 1.76 and 3.97-fold respectively in CC compared to normal tissue controls. siRNA and ChIP experiments in SiHa cells have demonstrated that KLF10 participates in immune response through regulation of IL6, IL25 and PSG2 and PSG5 genes. Using cervical tissues from KLF10−/− mice, we have identified down-regulation of PSG17, −21 and −23 and IL11. These results suggest that KLF10 may regulate immune system response genes in cervical cancer among other functions. KLF10 and PSG copy number variations and alterations in mRNA expression levels could represent novel molecular markers in CC.
Archives of Medical Research | 2018
Miriam Rodríguez-Esquivel; Juan Rosales; Rafael Castro; Teresa Apresa-García; Ónix Garay; Pablo Romero-Morelos; Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Ricardo López-Romero; Héctor Guerrero-Flores; Betsabé Morales; Mónica Mendoza-Rodríguez; Dejanira Mosso-Lara; Itzalia Núñez-Nolasco; Paola Castro-Alba; Sergio Enrique Meza-Toledo; Mauricio Salcedo
BACKGROUND AND AIMS Different Volatile Organic Compounds (VOCs) obtained from several human fluids (volatolome) has been reported as potential biomarkers for a great variety of diseases including cancer. At present, volatolomic profile data of the female genital area is scarce. METHODS To identify the VOCs related to the female genitourinary area of healthy and Cervical Cancer (CC)-affected women used a pad, as a non-invasive tool for sample gathering was necessary. Used pads were analyzed by Gas Chromatography-Mass Spectrometry. The data were subjected to Principal Component Analysis looking for a possible spectrum of VOCs that could help identify CC-affected patients. The diagnostic role of the VOCs was validated through Receiver Operating Characteristic (ROC) analysis. The area below the curve and the diagnostic sensitivity and specificity values were also evaluated. RESULTS The data showed great differences between female cancer and healthy patients groups; most of these VOCs belonging to the alkanes chemical classes. A group of VOCs were identified as common among CC patients, while others VOCs for healthy females. The ROC curve showed an optimal reach to diagnosis (89%), returning a 93% rate for sensitivity and specificity, indicating the VOCs identified in the samples could differentiate cancer patients from healthy females. CONCLUSIONS In summary, we have detected and identified specific VOCs from healthy women that are not present in CC-affected females and VOCs specific of CC-affected women. We are strengthening our findings to aid in the detection of VOCs that are potential biomarkers for cervical tumors.
Tumor Biology | 2014
Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Florinda Jiménez-Vega; Pablo Romero-Morelos; Mónica Mendoza-Rodríguez; Alejandra Mantilla; Miriam Rodríguez-Esquivel; Daniel Hernández; Ángeles Hernández; Guillermo Gómez-Gutierrez; Nancy Muñoz-Hernandez; Hugo Arreola-De la Cruz; Claudia Vargas-Requena; Cecilia Díaz-Hernández; Luis Serna-Reyna; Marco Antonio Meraz-Ríos; Cindy Bandala; Jorge Ortiz-Leon; Mauricio Salcedo
Archives of Medical Research | 2017
Daniel Marrero-Rodríguez; Hugo Arreola-De la Cruz; Keiko Taniguchi-Ponciano; Laura Gómez-Virgilio; Victor Huerta-Padilla; Gustavo Ponce-Navarrete; Sergio Andonegui-Elguera; Florinda Jiménez-Vega; Pablo Romero-Morelos; Miriam Rodríguez-Esquivel; Marco Antonio Meraz-Ríos; Ma. del Pilar Figueroa-Corona; Alberto Monroy; Oscar Pérez-González; Mauricio Salcedo
Revista médica del Instituto Mexicano del Seguro Social | 2015
Ricardo López-Romero; Daniel Marrero-Rodríguez; Pablo Romero-Morelos; Vanessa Villegas; Alejandra Valdivia; Hugo Arreola; Victor Huerta-Padilla; Mauricio Salcedo
Revista médica del Instituto Mexicano del Seguro Social | 2011
Pablo Romero-Morelos; Raúl Peralta-Rodríguez; Mónica Mendoza-Rodríguez; Alejandra Valdivia-Flores; Daniel Marrero-Rodríguez; Lucero Paniagua-García; Jade Rodríguez-Cabrales; Miriam Parra-Melquiádez; Mauricio Salcedo-Vargas
Medicina Clinica | 2018
Pablo Romero-Morelos; Cindy Bandala; Julián Jiménez-Tenorio; Mariana Valdespino-Zavala; Miriam Rodríguez-Esquivel; Reyna Anaid Gama-Ríos; Artfy Bandera; Mónica Mendoza-Rodríguez; Keiko Taniguchi; Daniel Marrero-Rodríguez; Ricardo López-Romero; Eva Ramón-Gallegos; Mauricio Salcedo
Medicina Clinica | 2017
Pablo Romero-Morelos; Arizbett Uribe-Jiménez; Cindy Bandala; Albros Poot-Vélez; Nora Ornelas-Corral; Miriam Rodríguez-Esquivel; Mariana Valdespino-Zavala; Keiko Taniguchi; Daniel Marrero-Rodríguez; Ricardo López-Romero; Mauricio Salcedo